![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Zika Funding Bill Skates Through House
Zika Funding Bill Skates Through House
![](https://www.fdanews.com/ext/resources/test/Drug-Images3/GreenDollarSign.gif?t=1433864063&width=430)
June 29, 2016
After ironing out funding differences with the Senate, the U.S. House of Representatives has passed a conference report that earmarks $315 million for research and development on combatting the Zika virus.
The conference report (H.R. 2755) would provide $230 million for the National Institutes of Health to support R&D for vaccines and diagnostic tests, while the Biomedical Advanced Research and Development Authority would receive $85 million for R&D activities.
Last week, it was approved 239-171, House records show. A Senate vote has not been scheduled.
Upcoming Events
-
21Oct